Big data and cardiovascular risk-insights into obesity, diabetes, and coronary heart disease

Marcus Dörr1,2,3

  • 1Institut für Community Medicine (SHIP/KEF), Universitätsmedizin Greifswald, Walter-Rathenau-Straße 48, 17475, Greifswald, Germany. marcus.doerr@uni-greifswald.de.

Herz
|June 24, 2025
PubMed

Insights

Big data research reveals that obesity and type 2 diabetes mellitus significantly increase cardiovascular disease risk. Understanding these links aids in developing precision prevention strategies for coronary heart disease.

Area of Science:

  • Cardiovascular epidemiology and public health.

Background:

  • Cardiovascular diseases (CVD) represent a significant global health challenge.
  • Obesity and type 2 diabetes mellitus (T2DM) are critical, modifiable risk factors for coronary heart disease (CHD).
  • Big data analytics are transforming cardiovascular research through advanced risk stratification and analysis of complex variable interactions.

Purpose of the Study:

  • To review the impact of big data on understanding the relationship between obesity, T2DM, and CHD.
  • To highlight key findings from large cohort studies and international collaborations.
  • To discuss methodological advancements in cardiovascular epidemiology.

Main Methods:

  • Analysis of large-scale cohort studies and international consortia data.
  • Integration of clinical, lifestyle, and molecular variables.
  • Application of novel approaches like polygenic risk scores and machine learning.
  • Utilizing real-world data for improved prediction and causal inference.

Main Results:

  • Obesity and diabetes exhibit regional variations in prevalence and incidence, often co-occurring with hypertension.
  • Diabetes independently increases CVD and mortality risk (2-4 fold), with earlier onset and poor glycemic control exacerbating outcomes.
  • The combined effect of obesity and diabetes is a primary contributor to the overall CHD burden.
  • Advanced methods have enhanced prediction accuracy and causal inference regarding these risk factors.

Conclusions:

  • Big data has significantly improved the understanding of cardiovascular risks linked to obesity and T2DM.
  • Enhanced risk prediction models and precision prevention strategies are now feasible.
  • Sustained investment in large cohorts, data standardization, and digital health is crucial for effective public health interventions to reduce global CVD burden.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
627
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
69
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
476
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
353
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
14.4K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
39